My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 100

    1.

    Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype.

    Asleh R, Blum S, Kalet-Litman S, Alshiek J, Miller-Lotan R, Asaf R, Rock W, Aviram M, Milman U, Shapira C, Abassi Z, Levy AP.

    Diabetes. 2008 Oct;57(10):2794-800. Epub 2008 Jul 3.PMID: 18599520 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial.

    Milman U, Blum S, Shapira C, Aronson D, Miller-Lotan R, Anbinder Y, Alshiek J, Bennett L, Kostenko M, Landau M, Keidar S, Levy Y, Khemlin A, Radan A, Levy AP.

    Arterioscler Thromb Vasc Biol. 2008 Feb;28(2):341-7. Epub 2007 Nov 21.PMID: 18032779 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Pharmacogenomic effect of vitamin E on kidney structure and function in transgenic mice with the haptoglobin 2-2 genotype and diabetes mellitus.

    Nakhoul FM, Miller-Lotan R, Awad H, Asleh R, Jad K, Nakhoul N, Asaf R, Abu-Saleh N, Levy AP.

    Am J Physiol Renal Physiol. 2009 Apr;296(4):F830-8. Epub 2009 Jan 28.PMID: 19176700 [PubMed - indexed for MEDLINE]Related articles

    4.

    Divergent effects of alpha-tocopherol and vitamin C on the generation of dysfunctional HDL associated with Diabetes and the Hp 2-2 genotype.

    Asleh R, Levy A.

    Antioxid Redox Signal. 2009 Sep 21. [Epub ahead of print]PMID: 19769483 [PubMed - as supplied by publisher]Related articles

    5.

    The effect of vitamin therapy on the progression of coronary artery atherosclerosis varies by haptoglobin type in postmenopausal women.

    Levy AP, Friedenberg P, Lotan R, Ouyang P, Tripputi M, Higginson L, Cobb FR, Tardif JC, Bittner V, Howard BV.

    Diabetes Care. 2004 Apr;27(4):925-30.PMID: 15047650 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Haptoglobin genotype is a regulator of reverse cholesterol transport in diabetes in vitro and in vivo.

    Asleh R, Miller-Lotan R, Aviram M, Hayek T, Yulish M, Levy JE, Miller B, Blum S, Milman U, Shapira C, Levy AP.

    Circ Res. 2006 Dec 8;99(12):1419-25. Epub 2006 Nov 2.PMID: 17082477 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Haptoglobin genotype- and diabetes-dependent differences in iron-mediated oxidative stress in vitro and in vivo.

    Asleh R, Guetta J, Kalet-Litman S, Miller-Lotan R, Levy AP.

    Circ Res. 2005 Mar 4;96(4):435-41. Epub 2005 Jan 20.PMID: 15662028 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease.

    Asleh R, Marsh S, Shilkrut M, Binah O, Guetta J, Lejbkowicz F, Enav B, Shehadeh N, Kanter Y, Lache O, Cohen O, Levy NS, Levy AP.

    Circ Res. 2003 Jun 13;92(11):1193-200. Epub 2003 May 15.PMID: 12750308 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Application of pharmacogenomics in the prevention of diabetic cardiovascular disease: mechanistic basis and clinical evidence for utilization of the haptoglobin genotype in determining benefit from antioxidant therapy.

    Levy AP.

    Pharmacol Ther. 2006 Nov;112(2):501-12. Epub 2006 Jul 18. Review.PMID: 16854468 [PubMed - indexed for MEDLINE]Related articles

    10.

    Pharmacogenomics in prevention of diabetic cardiovascular disease: utilization of the haptoglobin genotype in determining benefit from vitamin E.

    Levy AP, Blum S.

    Expert Rev Cardiovasc Ther. 2007 Nov;5(6):1105-11. Review.PMID: 18035926 [PubMed - indexed for MEDLINE]Related articles

    11.

    Increased renal hypertrophy in diabetic mice genetically modified at the haptoglobin locus.

    Miller-Lotan R, Herskowitz Y, Kalet-Litman S, Nakhoul F, Aronson D, Zoabi R, Asaf R, Ben-Izhak O, Sabo E, Lim SK, Baumann H, Berger FG, Levy AP.

    Diabetes Metab Res Rev. 2005 Jul-Aug;21(4):332-7.PMID: 15852445 [PubMed - indexed for MEDLINE]Related articles

    12.

    The effect of vitamin E, probucol, and lovastatin on oxidative status and aortic fatty lesions in hyperlipidemic-diabetic hamsters.

    El-Swefy S, Schaefer EJ, Seman LJ, van Dongen D, Sevanian A, Smith DE, Ordovas JM, El-Sweidy M, Meydani M.

    Atherosclerosis. 2000 Apr;149(2):277-86.PMID: 10729377 [PubMed - indexed for MEDLINE]Related articles

    13.

    Lipoprotein composition in NIDDM: effects of dietary oleic acid on the composition, oxidisability and function of low and high density lipoproteins.

    Dimitriadis E, Griffin M, Collins P, Johnson A, Owens D, Tomkin GH.

    Diabetologia. 1996 Jun;39(6):667-76.PMID: 8781762 [PubMed - indexed for MEDLINE]Related articles

    14.

    In vivo and in vitro studies establishing haptoglobin as a major susceptibility gene for diabetic vascular disease.

    Asleh R, Levy AP.

    Vasc Health Risk Manag. 2005;1(1):19-28. Review.PMID: 17319095 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Susceptibility of low- and high-density lipoproteins from diabetic subjects to in vitro oxidative modification.

    Julier K, Mackness MI, Dean JD, Durrington PN.

    Diabet Med. 1999 May;16(5):415-23.PMID: 10342342 [PubMed - indexed for MEDLINE]Related articles

    16.

    Haptoglobin genotype determines myocardial infarct size in diabetic mice.

    Blum S, Asaf R, Guetta J, Miller-Lotan R, Asleh R, Kremer R, Levy NS, Berger FG, Aronson D, Fu X, Zhang R, Hazen SL, Levy AP.

    J Am Coll Cardiol. 2007 Jan 2;49(1):82-7. Epub 2006 Dec 13.PMID: 17207726 [PubMed - indexed for MEDLINE]Related articles

    17.

    Hemoglobin and its scavenger protein haptoglobin associate with apoA-1-containing particles and influence the inflammatory properties and function of high density lipoprotein.

    Watanabe J, Grijalva V, Hama S, Barbour K, Berger FG, Navab M, Fogelman AM, Reddy ST.

    J Biol Chem. 2009 Jul 3;284(27):18292-301. Epub 2009 May 11.PMID: 19433579 [PubMed - indexed for MEDLINE]Related articles

    18.

    Hypothesis--haptoglobin genotype and diabetic nephropathy.

    Nakhoul FM, Miller-Lotan R, Awaad H, Asleh R, Levy AP.

    Nat Clin Pract Nephrol. 2007 Jun;3(6):339-44. Review.PMID: 17525716 [PubMed - indexed for MEDLINE]Related articles

    19.

    Haptoglobin genotype is a determinant of iron, lipid peroxidation, and macrophage accumulation in the atherosclerotic plaque.

    Levy AP, Levy JE, Kalet-Litman S, Miller-Lotan R, Levy NS, Asaf R, Guetta J, Yang C, Purushothaman KR, Fuster V, Moreno PR.

    Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):134-40. Epub 2006 Oct 26.PMID: 17068284 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Haptoglobin genotype is a major determinant of the amount of iron in the human atherosclerotic plaque.

    Moreno PR, Purushothaman KR, Purushothaman M, Muntner P, Levy NS, Fuster V, Fallon JT, Lento PA, Winterstern A, Levy AP.

    J Am Coll Cardiol. 2008 Sep 23;52(13):1049-51.PMID: 18848136 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is temporarily unavailable.

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    » See more...